New Italian Study Backs Association Between Some Diabetes Drugs and Development of Pancreatitis

In March, the United States Food and Drug Administration (FDA) issued a Drug Safety Communication, the contents of which stated that the agency was currently “investigating reports of possible increased risk of pancreatitis and pre-cancerous findings of the pancreas from incretin mimetic drugs for Type 2 diabetes.” While the FDA has not yet reached…

Read More

Steroid Use Among Teenagers

The drive to be a better athlete or the desire to be more “attractive” have prompted many teenagers across the United States to turn to steroids to help them get where they think they need to be. Unfortunately, the consequences of relying on steroids to enhance athletic performance or boost the physique have proven…

Read More

Manufacturer of Leukemia Drug Iclusig Asked to Suspend Marketing & Sales by FDA

Last Thursday, the United States Food and Drug Administration (FDA) announced that manufacturer Ariad Pharmaceuticals agreed to suspend its marketing and sales of the leukemia drug Iclusig. The announcement follows an intense investigation conducted by the FDA in which it was discovered that the drug can cause an increased frequency of blood clots and…

Read More

Another Warning from the FDA Speaks Against the Use of Nizoral

Less than a week ago, an online advisory notice was posted by the Food and Drug Administration (FDA) warning both pharmaceutical researches and drug companies alike against the use oral ketoconazole in their trials and examinations of between-drug interactions. Nizoral, the brand name for oral ketoconazole, has been connected to instances of adrenal gland…

Read More

New FDA Warning: Pfizer Drug Tygacil Raises Risk of Death

Last Friday, September 27th, the Food and Drug Administration (FDA) warned that the antibacterial drug Tygacil can increase the risk of death among users. For both intended and unintended uses of the drug, Tygacil can be fatal, as stated by the FDA last week. A product of Pfizer Inc., Tygacil will soon come with…

Read More

Death Toll from Acetaminophen Surpasses 1,500

Acetaminophen, a drug renowned for its safety, has been the source of more than 1,500 deaths in the United States in the last 10 years. The popular pain reliever is an active ingredient in brand-name drugs such as Tylenol and it is used by tens of millions of individuals on a weekly basis. However,…

Read More

New Labels on Tylenol Caps Will Warn of the Drug’s Fatal Risks

In October, a new warning label will be included on the caps of all bottles of Extra Strength Tylenol in the United States. In just over a month, a new, red warning alert will appear on every bottle of the medication, alerting users to the potentially fatal risks that can result from using too…

Read More

Post-Finasteride Syndrome Clinical Study Begins at Baylor College of Medicine

The Baylor College of Medicine (BCM) in Houston, Texas is the newest location for the next major clinic study to be funded by the Post-Finasteride Syndrome Foundation (PFS Foundation). Leading the study, which has been officially named the “Genetic and Epigenetic Studies on Post-Finasteride Syndrome Patients,” is Assistant Professor of Urology Dr. Mohit Khera….

Read More